Trials / Completed
CompletedNCT01482624
Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery
Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- TRB Chemedica AG · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this clinical investigation is to determine whether post-arthroscopic treatment with 10 ml of 0.5% sodium hyaluronate (VISCOSEAL® SYRINGE) can relief pain, improve mobility and promote joint recovery, compared to the standard arthroscopy procedure alone, in patients undergoing arthroscopic procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyaluronan (0.5%, 5 mg/10 ml) | Standard arthroscopic meniscal surgery and add-on treatment with VISCOSEAL® SYRINGE. Single injection of Hyaluronan directly after arthroscopic procedure. |
| PROCEDURE | Standard arthroscopic meniscal surgery | Standard arthroscopic meniscal surgery without add-on treatment. |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2011-11-30
- Last updated
- 2013-08-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01482624. Inclusion in this directory is not an endorsement.